Key Insights

Highlights

Treatment Research

2 treatments under study, led by Chemoembolization And Responsedependent Resection

Research Leaders

6 sponsors active, led by First People's Hospital of Chenzhou

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02138981Phase 4UnknownPrimary

Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Showing all 1 trials

Research Network

Common Treatments

  • Chemoembolization And Responsedependent Resection1
  • Immediate Resection1

Active Sponsors

  • First People's Hospital of Chenzhou1
  • Kaiping Central Hospital1
  • First Affiliated Hospital, Sun Yat-Sen University1
  • Sun Yat-sen University1
  • Third Affiliated Hospital, Sun Yat-Sen University1

Top Investigators

Activity Timeline